HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
6-Chloroimidazo(2,1-b)(1,3)thiazole-5-sulfonyl chloride → 1'-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dione
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 6-Chloroimidazo(2,1-b)(1,3)thiazole-5-sulfonyl chloride | HCID 2799717 | — |
| Edukt | Spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dione | HCID 57661820 | — |
| Produkt | 1'-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]spiro[naphtho[1,2-b][1,4]oxathiine-2,4'-piperidine]-5,6-dione | HCID 57661830 | — |
Reaktionsschritte
Compound 77 was synthesized using spiro[naphtho[1,2-b][1,4]oxathiine-2,4′-piperidine]-5,6-dione, 6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl chloride and conditions outlined in procedure P. M.p.=265-267° C.; 400 MHz 1H NMR (DMSO-d6) δ: 8.08-8.05 (m, 1H), 7.87-7.84 (m, 1H), 7.61-7.50 (m, 3H), 7.33-7.29 (m, 1H), 3.66-3.60 (m, 2H), 3.11 (s, 2H), 3.02-2.95 (m, 2H), 2.12-2.06 (m, 2H), 1.95-1.84 (m, 2H); LCMS: 522 [M+H].
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08039503B2 |
| Quelldatensatz | uspto-grants-2011_10 |
| ORD ID | ord-cf85769b0ddf479b92772d8f2ae2267c |
| Quellennotiz | uspto-grants-2011_10 |